These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28921427)

  • 41. Manipulation of the membrane binding site of vitamin K-dependent proteins: enhanced biological function of human factor VII.
    Shah AM; Kisiel W; Foster DC; Nelsestuen GL
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4229-34. PubMed ID: 9539719
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of warfarin in the nephrotic syndrome and effect on vitamin K-dependent clotting factors.
    Ganeval D; Fischer AM; Barre J; Pertuiset N; Dautzenberg MD; Jungers P; Houin G
    Clin Nephrol; 1986 Feb; 25(2):75-80. PubMed ID: 3698349
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Vitamin K-dependent blood coagulation factors--structure, function and biosynthesis (author's transl)].
    Katayama K; Fujikawa K; Titani K
    Tanpakushitsu Kakusan Koso; 1979; 24(7):924-41. PubMed ID: 394189
    [No Abstract]   [Full Text] [Related]  

  • 44. Vitamin K deficiency in male rats fed diets containing butylated hydroxytoluene (BHT).
    Suzuki H; Nakao T; Hiraga K
    Toxicol Appl Pharmacol; 1979 Sep; 50(2):261-6. PubMed ID: 92074
    [No Abstract]   [Full Text] [Related]  

  • 45. Industrial production of clotting factors: Challenges of expression, and choice of host cells.
    Kumar SR
    Biotechnol J; 2015 Jul; 10(7):995-1004. PubMed ID: 26099845
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vitamin K-dependent plasma proteins.
    Nelsestuen GL
    Methods Enzymol; 1984; 107():507-16. PubMed ID: 6239078
    [No Abstract]   [Full Text] [Related]  

  • 47. Inhibitors of 2-ketoglutarate-dependent dioxygenases block aspartyl beta-hydroxylation of recombinant human factor IX in several mammalian expression systems.
    Derian CK; VanDusen W; Przysiecki CT; Walsh PN; Berkner KL; Kaufman RJ; Friedman PA
    J Biol Chem; 1989 Apr; 264(12):6615-8. PubMed ID: 2708327
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heparin therapy in the case of acute liver cirrhosis.
    Fischer M; Gauss P; Korp W; Nobis H; Schnack B; Weissmann A
    Scand J Gastroenterol Suppl; 1973; 19():135-8. PubMed ID: 4515636
    [No Abstract]   [Full Text] [Related]  

  • 49. Enhanced functional recombinant factor IX production by human embryonic kidney cells engineered to overexpress VKORC1.
    Pakdaman SF; Vatandoost J; Bos MHA
    Biotechnol Prog; 2020 Mar; 36(2):e2938. PubMed ID: 31677255
    [TBL] [Abstract][Full Text] [Related]  

  • 50. All post-translational modifications except propeptide cleavage are required for optimal secretion of coagulation factor VII.
    Bolt G; Steenstrup TD; Kristensen C
    Thromb Haemost; 2007 Nov; 98(5):988-97. PubMed ID: 18000603
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improvement of the recombinant human coagulation factor IX expression by co-expression of a novel transcript of Drosophila γ carboxylase in a human cell line.
    Moniri Javadhesari S; Zomorodipour A
    Biotechnol Lett; 2020 Nov; 42(11):2147-2156. PubMed ID: 32514789
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of the propeptide and gamma-glutamic acid domain of factor IX for in vitro carboxylation by the vitamin K-dependent carboxylase.
    Stanley TB; Wu SM; Houben RJ; Mutucumarana VP; Stafford DW
    Biochemistry; 1998 Sep; 37(38):13262-8. PubMed ID: 9748333
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Isolated factor VII deficiency diagnosed after a life-threatening brain haemorrhage.
    Tsuda T; Okamoto Y; Sakaguchi R; Katayama N; Ota K
    J Int Med Res; 2000; 28(6):318-23. PubMed ID: 11191726
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of the hormones of the thyroid axis on the vitamin K-dependent plasma factors of blood coagulation (II, VII, IX, and X).
    Negrev NN; Radev RZ; Velikova MS; Anogeianaki A
    Int J Immunopathol Pharmacol; 2008; 21(1):221-6. PubMed ID: 18336749
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The influence of the thyroid function on the metabolic rate of prothrombin, factor VII, and factor X in the rat.
    van Oosterom AT; Mattie H; Hermens WT; Veltkamp JJ
    Thromb Haemost; 1976 Jun; 35(3):607-19. PubMed ID: 989968
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Basic mechanisms in blood coagulation.
    Davie EW; Fujikawa K
    Annu Rev Biochem; 1975; 44():799-829. PubMed ID: 237463
    [No Abstract]   [Full Text] [Related]  

  • 57. Expression of completely gamma-carboxylated recombinant human prothrombin.
    Jorgensen MJ; Cantor AB; Furie BC; Furie B
    J Biol Chem; 1987 May; 262(14):6729-34. PubMed ID: 3032975
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Theories of blood coagulation. Properties and interactions of blood clotting factors.
    Kazal LA
    Ann Clin Lab Sci (1971); 1971; 1(2):139-54. PubMed ID: 4949446
    [No Abstract]   [Full Text] [Related]  

  • 59. Identification and isolation of vitamin K-dependent proteins by HPLC.
    Litwiller RD; Jenny RJ; Mann KG
    Anal Biochem; 1986 Nov; 158(2):355-60. PubMed ID: 2949673
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hemostasis in surgical procedures.
    Quick AJ
    Surg Gynecol Obstet; 1969 Mar; 128(3):523-32. PubMed ID: 4180878
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.